Abstract
Background: A statement of measurement uncertainty describes the quality of a clinical assay analysis result, and uncertainty models of clinical assays can be used to evaluate and optimize laboratory protocols designed to minimize the measurement uncertainty associated with an assay. In this study, we propose a methodology to lend systematic structure to the uncertainty modeling process.
Methods: Clinical laboratory assays are typically classified based on the chemical reaction involved, and therefore, based on the assay analysis methodology. We use this fact to demonstrate that uncertainty models for assays within the same category are structurally identical in all respects except for the values of certain model parameters. This is accomplished by building uncertainty models for assays belonging to two categories – substrate assays based on optical absorbance analysis of endpoint reactions, and ion selective electrode (ISE) assays based on potentiometric measurements of electromotive force.
Results: Uncertainty models for the substrate assays and the ISE assays are built, and for each category, a general mathematical framework for the uncertainty model is developed. The parameters of the general framework that vary from assay to assay for each category are identified and listed.
Conclusions: Estimates of measurement uncertainty from the models were compared with estimates of uncertainty from quality control data from the clinical laboratory. We demonstrate that building a general modeling framework for each assay category and plugging in parameter values for each assay is sufficient to generate uncertainty models for an assay within a given category.
References
1. ISO/EN 15189. Medical laboratories – requirements for quality and competence. Geneva: ISO, 2012.Suche in Google Scholar
2. BIPM, IEC, IFCC, ISO, IUPAC, IUPAP and OIML. Guide to the expression of uncertainty in measurement. Geneva: ISO, 1993.Suche in Google Scholar
3. Joint Committee for the Guides in Metrology 100. Evaluation of measurement data – Guide to the expression of uncertainty in measurement. Available from: http://www.bipm.org/utils/common/documents/jcgm/JCGM_100_2008_E.pdf. Accessed on September, 2008.Suche in Google Scholar
4. Joint Committee for the Guides in Metrology 104. Evaluation of measurement data – an introduction to the Guide to the Expression of Uncertainty in Measurement and related documents. Available from: http://www.bipm.org/utils/common/documents/jcgm/JCGM_104_2009_E.pdf. Accessed on July, 2009.Suche in Google Scholar
5. Joint Committee for the Guides in Metrology 101. Evaluation of measurement data – Supplement 1 to the Guide to the Expression of Uncertainty in Measurement Propagation of distributions using a Monte Carlo method. Available from: http://www.bipm.org/utils/common/documents/jcgm/JCGM_101_2008_E.pdf. Accessed on September, 2008.Suche in Google Scholar
6. Kallner A, Waldenstrom J. Does the uncertainty of commonly performed glucose measurements allow identification of individuals at high risk for diabetes? Clin Chem Lab Med 1999;37:907–12.10.1515/CCLM.1999.134Suche in Google Scholar PubMed
7. Linko S, Ornemark U, Kessel R, Taylor PD. Evaluation of uncertainty of measurement in routine analytical chemistry – applications to determination of the substance concentration of calcium and glucose in serum. Clin Chem Lab Med 2002;40:391–8.10.1515/CCLM.2002.063Suche in Google Scholar PubMed
8. Patriarcia M, Castelli M, Corsetti F, Menditto A. Estimate of uncertainty of measurement from a single-laboratory validation study: application to the determination of lead in blood. Clin Chem 2004;50:1396–405.10.1373/clinchem.2003.029223Suche in Google Scholar
9. Burns M, Valdivia H. A procedural approach for the identification of sources of uncertainty associated with GM quantification and real-time quantitative PCR measurements. Eur Food Res Technol 2006;226:7–18.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000249623300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1007/s00217-006-0502-ySuche in Google Scholar
10. Leung GN, Ho EN, Kwok WH, Leung DK, Tang FP, Wan TS, et al. A bottom-up approach in estimating the measurement uncertainty and other important considerations for quantitative analyses in drug testing for horses. J Chromatogr A 2007;1163:237–46.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000249310800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.chroma.2007.06.035Suche in Google Scholar PubMed
11. Fuentes Arderiu X, Dot-Bach D. Measurement uncertainty in manual differential leukocyte counting. Clin Chem Lab Med 2009;47:112–5.10.1515/CCLM.2009.014Suche in Google Scholar PubMed
12. Aronsson T, de Verdier C-H, Groth T. Factors influencing the quality of analytical methods a systems analysis, with use of computer simulation. Clin Chem 1974;20:73848.10.1093/clinchem/20.7.738Suche in Google Scholar
13. Kallner A. Quality specifications based on the uncertainty of measurement. Scand J Clin Lab Invest 1999;59:513516.10.1080/00365519950185256Suche in Google Scholar
14. EURACHEM/CITAC Guide. Quantifying uncertainty in analytical measurements, 2nd ed. Uppsala: Eurachem, 2000.Suche in Google Scholar
15. Kristiansen J. Description of a generally applicable model for the evaluation of uncertainty in clinical chemistry. Clin Chem Lab Med 2001;39:220–31.10.1515/CCLM.2001.148Suche in Google Scholar
16. Burns M. Current practice in the assessment and control of measurement uncertainty in bio- analytical chemistry. Trends Anal Chem 2004;23:393–8.10.1016/S0165-9936(04)00523-0Suche in Google Scholar
17. Ramamohan V, Chandrasekar V, Abbott J, Klee GG, Yih Y. A Monte Carlo approach to the estimation and analysis of uncertainty in clinical laboratory measurement processes. IIE Trans Health Syst Eng 2012;2:1–13.10.1080/19488300.2012.665153Suche in Google Scholar
18. Ramamohan V, Chandrasekar V, Abbott J, Klee GG, Yih Y. Application of mathematical models of system uncertainty to evaluate the utility of assay calibration protocols. Clin Chem Lab Med 2012;50:1945–51.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000310695300012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Suche in Google Scholar PubMed
19. Ramamohan V, Chandrasekar V, Abbott J, Klee GG, Yih Y. Modeling uncertainty due to instrument drift in clinical laboratory measurement processes. Proc Indus Sys Eng Res Conf May 18–22, 2013. San Juan, Puerto Rico, USA.Suche in Google Scholar
©2013 by Walter de Gruyter Berlin Boston
Artikel in diesem Heft
- Letters to the Editor
- The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine
- Detection of unknown β-thalassemia cases from atypical HbA1c chromatograms
- Analytical study of a new turbidimetric assay for urinary neutrophil gelatinase-associated lipocalin (NGAL) determination
- The rare bipolar-contracted red cell significance and correlation with red cell volume
- Howell-Jolly body interference in reticulocyte counts
- PBMC expressed adiponectin mRNA is predictive of survival in patients with gastric cancer
- Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Development and validation of a rapid and reliable high-performance liquid chromatography method for methadone quantification in human plasma and saliva
- Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Still more discussion on the journal impact factor
- The order of draw, myth or science
- Masthead
- Masthead
- Editorial
- Multidisciplinarity and interdisciplinarity at work: the prenatal diagnosis
- Research Articles
- Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre
- Prenatal diagnosis of haemoglobinopathies: our experience of 523 cases
- Prenatal diagnosis of cystic fibrosis: an experience of 181 cases
- Prenatal diagnosis of haemophilia: our experience of 44 cases
- Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy
- Editorials
- Journal impact factor: the debate continues
- Estimation of uncertainty in measurements in the clinical laboratory
- Review
- Searching for genes involved in hypertension development in special populations: children and pre-eclamptic women. Where are we standing now?
- Opinion Paper
- More discussion on journal impact factor
- General Clinical Chemistry and Laboratory Medicine
- Category-specific uncertainty modeling in clinical laboratory measurement processes
- The order of draw: myth or science?
- Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children’s Study (NCS)
- Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women
- Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis
- Identification of an important potential confound in CSF AD studies: aliquot volume
- Cancer Diagnostics
- Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family
- Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Diabetes
- SAA1 genetic polymorphisms are associated with plasma glucose concentration in non-diabetic subjects
- Acknowledgment
- Acknowledgment
Artikel in diesem Heft
- Letters to the Editor
- The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine
- Detection of unknown β-thalassemia cases from atypical HbA1c chromatograms
- Analytical study of a new turbidimetric assay for urinary neutrophil gelatinase-associated lipocalin (NGAL) determination
- The rare bipolar-contracted red cell significance and correlation with red cell volume
- Howell-Jolly body interference in reticulocyte counts
- PBMC expressed adiponectin mRNA is predictive of survival in patients with gastric cancer
- Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Development and validation of a rapid and reliable high-performance liquid chromatography method for methadone quantification in human plasma and saliva
- Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Still more discussion on the journal impact factor
- The order of draw, myth or science
- Masthead
- Masthead
- Editorial
- Multidisciplinarity and interdisciplinarity at work: the prenatal diagnosis
- Research Articles
- Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre
- Prenatal diagnosis of haemoglobinopathies: our experience of 523 cases
- Prenatal diagnosis of cystic fibrosis: an experience of 181 cases
- Prenatal diagnosis of haemophilia: our experience of 44 cases
- Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy
- Editorials
- Journal impact factor: the debate continues
- Estimation of uncertainty in measurements in the clinical laboratory
- Review
- Searching for genes involved in hypertension development in special populations: children and pre-eclamptic women. Where are we standing now?
- Opinion Paper
- More discussion on journal impact factor
- General Clinical Chemistry and Laboratory Medicine
- Category-specific uncertainty modeling in clinical laboratory measurement processes
- The order of draw: myth or science?
- Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children’s Study (NCS)
- Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women
- Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis
- Identification of an important potential confound in CSF AD studies: aliquot volume
- Cancer Diagnostics
- Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family
- Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Diabetes
- SAA1 genetic polymorphisms are associated with plasma glucose concentration in non-diabetic subjects
- Acknowledgment
- Acknowledgment